Know Cancer

or
forgot password

Ghrelin - A Possible Opportunity to Improve Appetite, Nutritional State, Metabolic Integrity and Physical Functioning in Cancer Patients With Progressive Weight Loss


Phase 3
40 Years
80 Years
Not Enrolling
Both
Cancer

Thank you

Trial Information

Ghrelin - A Possible Opportunity to Improve Appetite, Nutritional State, Metabolic Integrity and Physical Functioning in Cancer Patients With Progressive Weight Loss


Randomized study with follow up evaluations each month until preterminal state. Cancer
patients will be randomised to either high dose or low dose of active treatment given as
daily injection.


Inclusion Criteria:



- Weight loss

Exclusion Criteria:

- Diabetes

Type of Study:

Interventional

Study Design:

Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Double Blind (Subject, Caregiver, Investigator), Primary Purpose: Treatment

Outcome Measure:

Food intake

Outcome Time Frame:

June 2008

Safety Issue:

No

Principal Investigator

Kent Lundholm, MD, prof

Investigator Role:

Principal Investigator

Investigator Affiliation:

Göteborg University

Authority:

Sweden: Medical Products Agency

Study ID:

kl4501123

NCT ID:

NCT00681486

Start Date:

October 2003

Completion Date:

July 2008

Related Keywords:

  • Cancer
  • Ghrelin
  • Nutrition
  • Cancer patients
  • Survival

Name

Location